Computationally engineered influenza antiviral affords broad prophylactic and therapeutic protection against influenza
Saved in:
Main Authors: | Deborah Heydenburg Fuller (Author), Merika Treants Koday (Author), Jorgen Nelson (Author), Aaron Chevalier (Author), Michael Koday (Author), Donald F. Smee (Author), Amy L. Hartman (Author), Douglas S. Reed (Author), Kelly Stefano Cole (Author), David Baker (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2016-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Labyrinthopeptin A1, a unique lantibiotic peptide with broad-spectrum antiviral (HIV, HSV, influenza, RSV and DENV) activity
by: Stephanie Gordts, et al.
Published: (2016) -
The Antiviral Role of Galectins toward Influenza A Virus Infection-An Alternative Strategy for Influenza Therapy
by: Chih-Yen Lin, et al.
Published: (2021) -
Immunogenicity of an adjuvanted broadly active influenza vaccine in immunocompromised and diverse populations
by: Dylan A. Hendy, et al.
Published: (2024) -
Influenza antiviral: Oseltamivir / Nur Nadrah Mat Supri
by: Mat Supri, Nur Nadrah
Published: (2023) -
T-705-Derived Prodrugs Show High Antiviral Efficacies against a Broad Range of Influenza A Viruses with Synergistic Effects When Combined with Oseltamivir
by: Benedikt Ganter, et al.
Published: (2023)